International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Immunohistochemical Study of Estrogen and Progesterone Receptor Expression in Endometrial Carcinoma

Author(s) Dr. Manju Singh Sirohi, Dr. Ankita Srivastava, Dr. Ashwani Tripathi, Dr. Tripti Singh, Dr. Chanchal Rana, Dr. Ajay Singh, Dr. U.S. Singh, Dr. Nikhilesh Kumar, Dr. Monika Gupta, Dr. Ved Prakash
Country India
Abstract BACKGROUND: Endometrial cancer is the fourth most common cancer affecting the women both from the point of view of incidence as well as mortality. ER/PR positivity helps to determine the need for hormonal treatment for endometrial cancer.
METERIAL AND METHOD It is a reterospective study on 22 histopathologically proven cases of endometrial carcinoma between the age group 30 to 80 yr from 1 Jan 2021 to 30 June 2022. Those cases with inadequate sample or with history of pregnancy were excluded from study. ER and PR expression was seen with Immunohistochemistry kit protocol.
RESULTS: Mean age of patients was 57.77 yrs. Endometrial carcinoma is more common in postmenopausal females. Bleeding per vaginum is the chief complaint. Most of the cases were well differentiated and of low grade.ER expression is positive in (15/17 88.2% )of cases of low grade /well differentiated , (4/4,100%) in moderately differentiated and not seen in high grade/ poorly differentiated endometrial carcinoma .PR expression seen in low grade/well differentiated is (14/17,82.4%) , in moderately differentiated is( 4/4,100%) and in high grade /poorly differentiated is (1/1, 100%)and not seen in high grade or poorly differentiated endometrial carcinoma .As the tumor invades deep in the myometrium ER and PR expression decreases.
CONCLUSION: ER and PR are important prognostic biomarkers to predict response to anti hormonal therapy.
Keywords Estrogen receptor, Progesterone receptor.
Field Medical / Pharmacy
Published In Volume 6, Issue 1, January-February 2024
Published On 2024-02-20
Cite This Immunohistochemical Study of Estrogen and Progesterone Receptor Expression in Endometrial Carcinoma - Dr. Manju Singh Sirohi, Dr. Ankita Srivastava, Dr. Ashwani Tripathi, Dr. Tripti Singh, Dr. Chanchal Rana, Dr. Ajay Singh, Dr. U.S. Singh, Dr. Nikhilesh Kumar, Dr. Monika Gupta, Dr. Ved Prakash - IJFMR Volume 6, Issue 1, January-February 2024. DOI 10.36948/ijfmr.2024.v06i01.12999
DOI https://doi.org/10.36948/ijfmr.2024.v06i01.12999
Short DOI https://doi.org/gtjt3d
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com